Comparison Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation

计划入组 260 人 · 首次发布于 2017 年 11 月 29 日

Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction

计划入组 70 人 · 首次发布于 2007 年 1 月 30 日

Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis

计划入组 1 人 · 首次发布于 2014 年 7 月 2 日

TIM-3-Fc-OX40L

TIM-3-Fc-CD40L

TIM-063

CLEVELAND CLINIC ABUDHABI L L C

United Arab Emirates

Xi'an No.4 Hospital

China

ARNOLD, L EUGENE

United States

CERo Therapeutics' CER-1236 Shows Promise in Preclinical Ovarian Cancer Models

FDA Clears CERo Therapeutics' IND for Novel CAR-T Therapy CER-1236 in Solid Tumors

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board as Oral TIM-3/TIM-4 Agonist Advances Through Phase 1b Trials